secwatch.observer — SEC 8-K summary
======================================

Issuer:     Rein Therapeutics, Inc. (RNTX)
CIK:        0001420565
Form:       8-K
Filed at:   2024-07-26T23:59:59+00:00
Accession:  0001193125-24-186279
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Aileron Therapeutics enters into ATM equity distribution agreement for up to $50M with Citizens JMP
--------------------------------------------------------------------------------

- New Equity Distribution Agreement with Citizens JMP Securities for at-the-market sales of common stock up to $50M.
- Terminated prior Capital on Demand agreement with JonesTrading and William Blair effective July 26, 2024.
- Agent commission set at 3.0% of gross proceeds from share sales.
- Shares sold under existing shelf registration statement; no specific amount required to be sold.
- Offering conducted on Nasdaq Capital Market; either party may suspend or terminate upon notice.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1420565/000119312524186279/0001193125-24-186279-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1420565/000119312524186279/d868344d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-186279

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer